CoChat

STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy

Open access

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

Significance: It is increasingly recognized that chronic neuroinflammation is causally relevant to neurodegeneration. In Parkinson’s disease (PD), α-synuclein pathology activates inflammatory signaling that disturbs parenchymal homeostasis and disrupts neuron-glia interactions. Herein, we report that the innate immune cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) DNA-sensing pathway is activated in a mouse model of α-synucleinopathy and parkinsonism, leading to type-I interferon activation that precedes the onset of neurodegeneration. Remarkably, STING-deficient mice were protected from dopaminergic neuron loss in this model. We also show that αSyn aggregates can increase STING expression and augment canonical STING activation, suggesting a possible generalized propensity for exaggerated antiviral responses in neurological states with STING elevation. Our results suggest that STING inhibition may be therapeutic in idiopathic PD and possibly other human α-synucleinopathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.2118819119

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. αSyn-PFFs cause glial genotoxicity and cGAS/STING activation in vitro. (A) Representative Western blot analysis of cytoplasmic (Triton X-100 soluble) cell fractions isolated from primary cerebrocortical cultures of mouse neurons or mixed cultures of microglia and astrocytes (MA) treated with PBS vehicle or α-synuclein preformed fibrils (αSyn-PFF) for 24 h. (B) Representative Western blot analysis of the DNA double-strand break marker γH2A.X in MA glial cultures treated as in (A). (C) Representative Western blot of pTBK1 in noncytoplasmic fractions (Triton X-100 insoluble) of MA cultures treated for 24 h with PBS vehicle or αSyn-PFF ± STING inhibitor H-151 (5 µM). (D, E) Quantifications of actin-normalized γH2A.X band intensity from B (n = 3) or pTBK1 band intensity from C (n = 5). P value from two-tailed t test (t = 6.13, df = 4) in D and from one-way ANOVA with Tukey post hoc comparisons in E (PBS vs. PFF: q = 11.32; PFF vs. PFF+H151: q = 6.42; df = 12). (F) Enzyme-linked immunosorbent assay (ELISA) for the cGAS activation product and STING ligand 2′3′-cyclic-GMP-AMP (cGAMP) in MA glial cultures treated with PBS vehicle or αSyn-PFF for 24 h (n = 6). P value from two-tailed t test (t = 5.43, df = 10).
Fig. 1. αSyn-PFFs cause glial genotoxicity and cGAS/STING activation in vitro. (A) Representative Western blot analysis of cytoplasmic (Triton X-100 soluble) cell fractions isolated from primary cerebrocortical cultures of mouse neurons or mixed cultures of microglia and astrocytes (MA) treated with PBS vehicle or α-synuclein preformed fibrils (αSyn-PFF) for 24 h. (B) Representative Western blot analysis of the DNA double-strand break marker γH2A.X in MA glial cultures treated as in (A). (C) Representative Western blot of pTBK1 in noncytoplasmic fractions (Triton X-100 insoluble) of MA cultures treated for 24 h with PBS vehicle or αSyn-PFF ± STING inhibitor H-151 (5 µM). (D, E) Quantifications of actin-normalized γH2A.X band intensity from B (n = 3) or pTBK1 band intensity from C (n = 5). P value from two-tailed t test (t = 6.13, df = 4) in D and from one-way ANOVA with Tukey post hoc comparisons in E (PBS vs. PFF: q = 11.32; PFF vs. PFF+H151: q = 6.42; df = 12). (F) Enzyme-linked immunosorbent assay (ELISA) for the cGAS activation product and STING ligand 2′3′-cyclic-GMP-AMP (cGAMP) in MA glial cultures treated with PBS vehicle or αSyn-PFF for 24 h (n = 6). P value from two-tailed t test (t = 5.43, df = 10).CC BY-NC-ND · PubMed Central
Fig. 2. Striatal α-synucleinopathy causes microglial DNA damage and STING-dependent interferon induction. (A) Representative immunofluorescence staining for striatal pTBK1 in tissues prepared from WT mice 3 mo after bilateral striatal injection with αSyn-PFF. (B) Quantification of the signal intensity for pTBK1 in microglia (Iba1+) or nonmicroglial (Iba1−) cells of the striatum and the total microglial pTBK1 as measured by the proportion of Iba1 signal with colocalized pTBK1. All data are mean ± SEM. P values from unpaired t tests (pTBK Iba1−: t = 12.65; pTBK Iba1+: t = 14.8; Iba1+ proportion pTBK+: t = 3.18, all df = 7). (C) Representative immunofluorescence staining with orthogonal Z-stack views for striatal γH2A.X in tissues prepared from WT mice 3 mo after bilateral striatal injection with αSyn-PFF. (D) Quantification of the total nuclear (Hoechst+) and microglial (Iba1+) γH2A.X measured by the proportion with colocalized γH2A.X. All data are mean ± SEM P values from unpaired t tests (γH2A.X: t = 3.56; Iba1+ γH2A.X: t = 4.59, all df = 8). (E) qPCR was used to measure transcription of Sting and inflammatory markers in striatal tissue of WT or Stinggt mice 3 mo after unilateral striatal injection with αSyn-PFF or PBS vehicle. All data are mean ± SEM P values from unpaired t test for Sting upregulation in WT mice injected with PFF (t = 5.27, df = 9) and two-way ANOVA with Tukey post hoc multiple comparisons tests for all other targets (test statistics in SI Appendix, Dataset S1).
Fig. 2. Striatal α-synucleinopathy causes microglial DNA damage and STING-dependent interferon induction. (A) Representative immunofluorescence staining for striatal pTBK1 in tissues prepared from WT mice 3 mo after bilateral striatal injection with αSyn-PFF. (B) Quantification of the signal intensity for pTBK1 in microglia (Iba1+) or nonmicroglial (Iba1−) cells of the striatum and the total microglial pTBK1 as measured by the proportion of Iba1 signal with colocalized pTBK1. All data are mean ± SEM. P values from unpaired t tests (pTBK Iba1−: t = 12.65; pTBK Iba1+: t = 14.8; Iba1+ proportion pTBK+: t = 3.18, all df = 7). (C) Representative immunofluorescence staining with orthogonal Z-stack views for striatal γH2A.X in tissues prepared from WT mice 3 mo after bilateral striatal injection with αSyn-PFF. (D) Quantification of the total nuclear (Hoechst+) and microglial (Iba1+) γH2A.X measured by the proportion with colocalized γH2A.X. All data are mean ± SEM P values from unpaired t tests (γH2A.X: t = 3.56; Iba1+ γH2A.X: t = 4.59, all df = 8). (E) qPCR was used to measure transcription of Sting and inflammatory markers in striatal tissue of WT or Stinggt mice 3 mo after unilateral striatal injection with αSyn-PFF or PBS vehicle. All data are mean ± SEM P values from unpaired t test for Sting upregulation in WT mice injected with PFF (t = 5.27, df = 9) and two-way ANOVA with Tukey post hoc multiple comparisons tests for all other targets (test statistics in SI Appendix, Dataset S1).CC BY-NC-ND · PubMed Central
Fig. 3. STING knockout is neuroprotective in the αSyn-PFF model. (A–C) Behavioral analyses of WT and Stinggt mice 9 mo after bilateral striatal injection with αSyn-PFF or PBS vehicle. Results from accelerating rotarod (A), grip strength test (B), and pole test (C) presented as mean ± SEM (10–21 mice per group). P values are derived from two-way ANOVA with Tukey post hoc comparisons (test statistics in SI Appendix, Dataset S2). (D) Representative immunohistochemistry for tyrosine hydroxylase (TH) counterstained with a thionin Nissl stain in ventral midbrain of WT and Stinggt mice in fixed cryopreserved tissue sections. (E, F) Unbiased stereological counts of TH+ neurons (E) and TH−, Nissl+ neurons (F) in the SNpc. Data are mean ± SEM P values from two-way ANOVA with Tukey post hoc comparisons (test statistics in SI Appendix, Dataset S2). (G) Representative immunostaining for pS129-αSyn (green) and TH (red) with Hoechst counterstain. Scale bar = 100 μm. (H) Quantification of the percentage of TH-positive neuronal somas with pS129-αSyn+ inclusions in the substantia nigra section with maximal pS129-αSyn+ inclusion density for each mouse (10 mice per group). ND = No pS129-αSyn+ inclusions detected. P value from two-tailed nonparametric Mann-Whitney test (medians: 3.25 vs. 0.92; n = 10; U = 7). (I) Striatal dopamine measurement by HPLC. Two-way ANOVA with Holm-Šídák post hoc multiple comparisons test (df = 40; t = 3.45 [WT-PBS vs. WT-PFF], t = 2.26 [WT-PFF vs. Stinggt-PFF).
Fig. 3. STING knockout is neuroprotective in the αSyn-PFF model. (A–C) Behavioral analyses of WT and Stinggt mice 9 mo after bilateral striatal injection with αSyn-PFF or PBS vehicle. Results from accelerating rotarod (A), grip strength test (B), and pole test (C) presented as mean ± SEM (10–21 mice per group). P values are derived from two-way ANOVA with Tukey post hoc comparisons (test statistics in SI Appendix, Dataset S2). (D) Representative immunohistochemistry for tyrosine hydroxylase (TH) counterstained with a thionin Nissl stain in ventral midbrain of WT and Stinggt mice in fixed cryopreserved tissue sections. (E, F) Unbiased stereological counts of TH+ neurons (E) and TH−, Nissl+ neurons (F) in the SNpc. Data are mean ± SEM P values from two-way ANOVA with Tukey post hoc comparisons (test statistics in SI Appendix, Dataset S2). (G) Representative immunostaining for pS129-αSyn (green) and TH (red) with Hoechst counterstain. Scale bar = 100 μm. (H) Quantification of the percentage of TH-positive neuronal somas with pS129-αSyn+ inclusions in the substantia nigra section with maximal pS129-αSyn+ inclusion density for each mouse (10 mice per group). ND = No pS129-αSyn+ inclusions detected. P value from two-tailed nonparametric Mann-Whitney test (medians: 3.25 vs. 0.92; n = 10; U = 7). (I) Striatal dopamine measurement by HPLC. Two-way ANOVA with Holm-Šídák post hoc multiple comparisons test (df = 40; t = 3.45 [WT-PBS vs. WT-PFF], t = 2.26 [WT-PFF vs. Stinggt-PFF).CC BY-NC-ND · PubMed Central
Fig. 4. STING is up-regulated in human PD. (A) Representative Western blot analysis of proteins in substantia nigra tissue from autopsied cases of diagnosed PD and controls. (B, C) Quantification of STING (B) and pTBK1 (C) band intensities after normalization to actin and TBK1, respectively (n = 5), P values from two-tailed nonparametric Mann-Whitney test (STING: medians 0.88, 2.20; n = 5; U = 0. pTBK1: medians 1.30, 1.29; n = 5; U = 11). (D) Linear regression analysis of the relationship between STING and pSer129-αSyn band intensities in (A), including percent explained variance (R2) and exact P value.
Fig. 4. STING is up-regulated in human PD. (A) Representative Western blot analysis of proteins in substantia nigra tissue from autopsied cases of diagnosed PD and controls. (B, C) Quantification of STING (B) and pTBK1 (C) band intensities after normalization to actin and TBK1, respectively (n = 5), P values from two-tailed nonparametric Mann-Whitney test (STING: medians 0.88, 2.20; n = 5; U = 0. pTBK1: medians 1.30, 1.29; n = 5; U = 11). (D) Linear regression analysis of the relationship between STING and pSer129-αSyn band intensities in (A), including percent explained variance (R2) and exact P value.CC BY-NC-ND · PubMed Central
Fig. 5. αSyn-PFFs prime microglial cGAS/STING for maximal signaling. (A, B) Representative Western blots (A) and quantification (B) of cytoplasmic STING and cGAS in MA cultures treated as in A (n = 6). P values from two-tailed t tests (STING: t = 21.2; cGAS: t = 2.28; TBK1: t = 2.29; all df = 10). (C) Approach to test the hypothesis that STING upregulation in αSyn-PFF-treated microglia primes more potent immune responses to STING ligands. DMXAA, 5,6-dimethylxanthenone-4-acetic acid; DMSO, dimethyl sulfoxide. (D) qPCR was used to measure the priming of microglial interferon activation by 24 h αSyn-PFF treatment followed by a 120-min secondary treatment with the STING activator DMXAA (10 μg/mL) or vehicle (DMSO). P values from two-way ANOVA followed by Tukey’s post hoc test (test statistics in SI Appendix, Dataset S3). (E) ELISA analysis of microglial cell culture media cytokines after pretreatment with αSyn-PFF or PBS vehicle for 24 h followed by 4 h exposure to DMSO or DMXAA (10 μg/mL) P values from two-way ANOVA followed by Tukey’s post hoc test (test statistics in SI Appendix, Dataset S3).
Fig. 5. αSyn-PFFs prime microglial cGAS/STING for maximal signaling. (A, B) Representative Western blots (A) and quantification (B) of cytoplasmic STING and cGAS in MA cultures treated as in A (n = 6). P values from two-tailed t tests (STING: t = 21.2; cGAS: t = 2.28; TBK1: t = 2.29; all df = 10). (C) Approach to test the hypothesis that STING upregulation in αSyn-PFF-treated microglia primes more potent immune responses to STING ligands. DMXAA, 5,6-dimethylxanthenone-4-acetic acid; DMSO, dimethyl sulfoxide. (D) qPCR was used to measure the priming of microglial interferon activation by 24 h αSyn-PFF treatment followed by a 120-min secondary treatment with the STING activator DMXAA (10 μg/mL) or vehicle (DMSO). P values from two-way ANOVA followed by Tukey’s post hoc test (test statistics in SI Appendix, Dataset S3). (E) ELISA analysis of microglial cell culture media cytokines after pretreatment with αSyn-PFF or PBS vehicle for 24 h followed by 4 h exposure to DMSO or DMXAA (10 μg/mL) P values from two-way ANOVA followed by Tukey’s post hoc test (test statistics in SI Appendix, Dataset S3).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 50 references

Cited by

See all 277

Metadata

Authors
Hinkle, J. T., Patel, J., Panicker, N., Karuppagounder, S. S., Biswas, D., Belingon, B., Chen, R., Brahmachari, S., Pletnikova, O., Troncoso, J. C., Dawson, V. L., & Dawson, T. M.
Affiliations
  • Johns Hopkins University (US)
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205
Corresponding author
  • Dawson, Valina L.
  • Dawson, Ted M.
Venue
Proceedings of the National Academy of Sciences
Published
2022-04-08
Volume
119
Issue
15
Pages
e2118819119-e2118819119
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W4223610665
Cited by
240
References
50
Citations by year
2026: 62 · 2025: 56 · 2024: 66 · 2023: 41 · 2022: 15
FWCI
24.34
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • JPB Foundation (n/a)
  • Farmer Family Foundation (n/a)
  • HHS | NIH | National Institute of General Medical Sciences (T32 GM136577)
  • HHS | NIH | National Institute on Aging (F30AG067643, K99AG066862, P50AG05146)
  • Maryland Stem Cell Research Fund (2017-MSCRFF-3838)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords
STING, synucleinopathies, Parkinson's disease, neuroinflammation, dopaminergic neuron loss, microglia, TBK1, DNA double-strand break response, γH2AX, interferon response, preformed fibrils, substantia nigra pars compacta, mitochondrial DNA damage, oxidative stress
MeSH terms
Synucleinopathies, Neuroinflammatory Diseases, STING Protein, Animals, Interferon Type I, Membrane Proteins, Nucleotidyltransferases, Parkinson Disease, Signal Transduction, Neurodegenerative Diseases, Mice, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy. https://app.cochat.ai/papers/10.1073/pnas.2118819119
The paper
Hinkle, J. T., Patel, J., Panicker, N., Karuppagounder, S. S., Biswas, D., Belingon, B., Chen, R., Brahmachari, S., Pletnikova, O., Troncoso, J. C., Dawson, V. L., & Dawson, T. M. (2022). STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2118819119

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.